OracleBio will be attending the 6th Digital Pathology & AI Congress, which takes place from the 5th to 6th of December 2019 in London, UK.
OracleBio will be exhibiting throughout the meeting.
OracleBio is a highly specialised image analysis CRO (contract research organization) providing high precision, quantitative, digital image analysis services to support pre-clinical and clinical research. Using both Indica Labs HALO™ and Visiopharm Oncotopix® image analysis software platforms we can deliver accurate and detailed quantification of nuclear, membrane and cytoplasmic markers on a cell-by-cell basis within Histology, IHC and ISH tissue sections. The management and employees of the company have over 100 years of combined experience of working within the R&D functions of medium and large Pharma companies and provide the type of high-quality service expected of a specialist image analysis CRO. Click here to find out more information about how our services can support your R&D.
The Digital Pathology & AI Congress will cover the latest advancements in digital pathology whole slide imaging (WSI), digital image analysis and the applications of artificial intelligence in both primary diagnosis and clinical research. The congress will also explore the latest strategies in the implementation and wide-spread adoption of digital pathology technologies in the lab. To find out more, please click here.
Lorcan Sherry, Chief Scientific Officer, and Keith Bowers, Senior Business Development Manager, will be in attendance throughout the meeting. If you would like to learn more about OracleBio’s services or arrange a meeting please contact us.
To keep up to date with all OracleBio news and events, follow us on LinkedIn by clicking the button below: